Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-16-029221)

Filing Details

Accession Number:: 0001179110-16-029221
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-09-01 18:18:46
Reporting Period:: 2016-08-30

Filing Date:: 2016-09-01
Accepted Time:: 2016-09-01 18:18:46
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1034842	Rigel Pharmaceuticals Inc	RIGL	Pharmaceutical Preparations (2834)	943248524

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1190275	G Donald Payan	Rigel Pharmaceuticals, Inc. 1180 Veterans Blvd. South San Francisco CA 94080	Evp, Pres. Discovery&Research	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2016-08-30	5,303	$4.00	53,031	No	4	S	Indirect	By Family Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Family Trust

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 1, 2016.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.000 to $4.002, inclusive.
The Reporting Person is a Co-Trustee.